Health Tip: Treating Endometriosis
Title: Health Tip: Treating EndometriosisCategory: Health NewsCreated: 3/28/2019 12:00:00 AMLast Editorial Review: 3/28/2019 12:00:00 AM
Condition: Endometriosis Interventions: Drug: BAY2328065 LSF; Drug: BAY2328065 tablet; Drug: Placebo LSF; Drug: Placebo tablet; Drug: Midazolam Sponsor: Bayer Not yet recruiting
Publication date: Available online 19 July 2019Source: Journal of Minimally Invasive GynecologyAuthor(s): Aude Jayot, Sofiane Bendifallah, Carole Abo, Alexandra Arfi, Clémentine Owen, Emile DaraiABSTRACTLaparoscopic discoid colorectal resection is a surgical option for bowel endometriosis, one of the most severe forms of endometriosis. However, no study has clearly analysed the feasibility, or the complication and recurrence rates of the procedure in a homogeneous population with specific criteria for discoid resection. The aims were to evaluate the rate of conversion to segmental resection, the need for double disc...
ConclusionExtreme cases of DIE involving the pelvic side wall require surgical finesse when normal planes of dissection are obliterated. Knowledge of retroperitoneal anatomy is critical in order to overcome unexpected lateral pelvic side wall endometriosis as the disease is rarely confined to the surface. Innovative surgical thinking complemented by an array of surgical tools will ultimately allow the surgeon to master these difficult endometriotic resections.
ConclusionsThe present study demonstrated that aerial parts of U. dioica exhibited promising activity in the endometriosis rat model due to its flavonoids.Graphical abstract
This study revealed the possible occurrence and recurrence risk factors of ovarian endometriosis malignancy using univariate and multivariate statistics analyses. What are the implications of these findings for clinical practice and/or further research? A clinical retrospective study with a longer follow-up period is suggested for assessing the occurrence and recurrence risk factors for ovarian endometriosis malignancies. PMID: 31307261 [PubMed - as supplied by publisher]
EU-funded researchers are studying the molecular mechanisms behind endometriosis in the hope of finding new treatment options for the millions of women around the world who suffer from the chronic inflammatory disease.
CONCLUSION: The EFI can be reproduced reliably by different raters, further supporting its use in daily clinical practice as the principal clinical tool for postoperative fertility counselling/management of women with endometriosis. This article is protected by copyright. All rights reserved. PMID: 31319445 [PubMed - as supplied by publisher]
The functional impairment of common gynecologic diseases is astounding. Women have likely curtailed their activities due to pelvic pain or heavy and unpredictable menstrual bleeding for centuries. However, women increasingly work outside the home or are the main or sole wage-earner for a family, which makes it easier to quantitate the economic impact of this impairment. Although the article by Pokrzwinski and colleagues (1) in this issue of Fertility and Sterility focuses on endometriosis and the investigational oral GnRH antagonist elagolix, there are a number of more generalizable issues that it addresses.
To systematically compare the endometrial microbiota in infertile women with and without chronic endometritis (CE), as diagnosed by a quantitative and reference range-based method.
AbstractA 37-year-old woman experienced repeated catamenial hemoptysis. She had a history of intrauterine curettage. Computed tomography (CT) showed ground glass opacity (GGO) in the right upper lung lobe. We suspected pulmonary endometriosis and scheduled surgery coincides with her menstrual cycle. Then she underwent surgical resection after pre-operative CT-guided marking of the pulmonary endometrial lesion. A yellowish change of the pleura was observed near the marking and the lesion was resected using video-assisted thoracoscopic surgery. Histopathologically, endometrial glands and intimal interstitium were evident. Sh...